Skip to content

Long term care for Heart Failure patients; HF clinics versus primary care.

Heart Failure clinics versus primary care in the long-term follow-up of patients with chronic heart failure: COACH-2.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28583
Enrollment
200
Registered
2009-03-18
Start date
2009-04-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronisch Hartfalen, Chronic Heart Failure

Interventions

HF patients in both intervention groups will be followed-up according to the Dutch Multidisciplinary Guideline on Chronic Heart Failure.

Sponsors

University Medical Center Groningen, Department of Cardiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients are eligible when they; 1. Have symptomatic, systolic HF (NYHA II-III); 2. Are visiting the Heart Failure clinic of one of the participating centres; 3. Have HF with evidence for structural underlying ventricular dysfunction (LVEF<40%); 4. Are up titrated to optimal pharmacological treatment (notably use of adequate dosages of ACE-inhibitors/ARBs and beta blockers); 5. Are in a stable condition; no hospital admissions in the previous month, no visits at the emergency unit for decompensation in the previous month, no unplanned medication changes in the previous month; 6. Have received information and education on heart failure and the required life style changes following a pre-specified protocol; 7. Are aged above 18 years.

Exclusion criteria

Exclusion criteria: Patients will be excluded from the study when; 1. Patient management by a cardiologist planned for diagnostics or treatment is needed; 2. The patient has restrictions that render patients to fill in data collection materials (non-mastering of the Dutch language); 3. The patient has a life expectancy shorter than 6 months; 4. The patient has a current psychiatric disorder as documented in the medical record.

Design outcomes

Primary

MeasureTime frame
1. Guideline Adherence with Pharmacologicial treatment of Heart Failure; 2. Patient compliance with medication.

Secondary

MeasureTime frame
1. Guideline Adherence Optimal Dose; 2. Number of hospital readmissions; 3. Mortality; 4. Patient compliance with lifestyle recommendations on diet, fluid and weighing; 5. Quality of Life; 6. Guideline Adherence devices

Contacts

Public ContactM.L.A. Luttik

Postbus 30001

m.l.a.luttik@thorax.umcg.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)